Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Barbara Burtness MD
Barbara Burtness MD Advisory Board
David Henry MD
David Henry MD Advisory Board
Guru Sonpavde MD
Guru P. Sonpavde MD Advisory Board
See All Experts
Published in Oncology

News · December 16, 2022

ASH 2022: Blinatumomab + Consolidation Chemotherapy Improves Overall Survival

Findings seen among patients with B-lineage acute lymphoblastic leukemia who had nonmeasurable residual disease after intensification chemotherapy

PracticeUpdate Editorial Team

 

 Save  Recommend
 Share

Further Reading

Most Read This Week

Recently Updated